Chronic corticosterone injections induce a decrease of ATP levels and sustained activation of AMP-activated protein

Yunan Zhao1, Jia Shen, Hui Su

  • 1Laboratory of Pharmaceutical Sciences, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China.

Brain Research
|January 1, 2008
PubMed

Insights

Chronic corticosterone exposure in mice caused depression-like behaviors and altered hippocampal energy metabolism. Sustained activation of AMP-activated protein kinase (AMPK) may underlie these effects, despite unchanged adenylate kinase (AK) levels.

Area of Science:

  • Neuroscience
  • Metabolic Research
  • Behavioral Science

Background:

  • Chronic corticosterone exposure is linked to hippocampus damage and depression-like behaviors.
  • Adenylate kinase (AK) and AMP-activated protein kinase (AMPK) are crucial for neuronal energy metabolism.
  • Dysregulation of AK or AMPK systems can impair brain function, particularly in energy-demanding situations.

Purpose of the Study:

  • To investigate the impact of chronic corticosterone exposure on hippocampal energy metabolism.
  • To examine the roles of AK and AMPK in corticosterone-induced depression-like behaviors in mice.

Main Methods:

  • Male C57BL/6N mice received chronic corticosterone injections.
  • Hippocampal tissues were analyzed for energy levels, AMP:ATP ratio, and AK1/AMPK protein and mRNA.
  • Depression-like behaviors were assessed in the mice.

Main Results:

  • Corticosterone injections induced depression-like behavior and decreased hippocampal energy levels.
  • A sustained increase in the AMP:ATP ratio was observed in hippocampal tissues.
  • While AK1 levels remained unaffected, AMPK showed sustained activation.

Conclusions:

  • Sustained activation of AMPK in the hippocampus may be a key mechanism underlying corticosterone-induced depression-like behavior.
  • Energy metabolism disturbances, indicated by increased AMP:ATP ratio, are associated with these behavioral changes.
  • Further research into AMPK's role could reveal therapeutic targets for depression.